PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-65.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-75.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-143.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-144.21%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-146.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-146.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-146.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Diluted share change of 0.00% while 4997.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.04%
Negative 10Y revenue/share CAGR while 4997.T stands at 39.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.58%
Negative 5Y CAGR while 4997.T stands at 32.54%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-6.46%
Negative 3Y CAGR while 4997.T stands at 14.94%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR in line with 4997.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
91.24%
Positive 10Y CAGR while 4997.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
57.94%
Positive 5Y CAGR while 4997.T is negative. John Neff might view this as a strong mid-term relative advantage.
-150.33%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
208.94%
5Y equity/share CAGR above 1.5x 4997.T's 61.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
15.17%
Below 50% of 4997.T's 47.67%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
44.95%
We show growth while 4997.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.40%
Positive asset growth while 4997.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-4.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
45.19%
We have some new debt while 4997.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while 4997.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
35.66%
SG&A growth of 35.66% while 4997.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.